Skip to main content
CodeRx
↑↓ move↵ open CodeRx

Billing and Coding: Transthoracic Echocardiography (TTE)

Medicare Coverage Database article A57306

Article

Contractor
CGS Administrators, LLC
States (A/B MAC)
KY, OH
Effective
Oct 1, 2026
Contractor numbers
15101, 15102, 15201, 15202
Read the article's coding instructions on CMS — which codes go together, documentation, and frequency limits — before billing. CodeRx lists the codes, not the instructions.

Drug codes in this article

HCPCS Level II drug codes the article lists (other codes it lists are not shown).

Covered ICD-10-CM codes (1,461)

Diagnosis codes the article lists as supporting medical necessity, grouped as in the article, with CMS's descriptions.

Group 1 · 1100 codes

  • A18.84Tuberculosis of heart
  • A36.81Diphtheritic cardiomyopathy
  • A39.53Meningococcal pericarditis
  • A40.0Sepsis due to streptococcus, group A
  • A40.1Sepsis due to streptococcus, group B
  • A40.3Sepsis due to Streptococcus pneumoniae
  • A40.8Other streptococcal sepsis
  • A40.9Streptococcal sepsis, unspecified
  • A41.01Sepsis due to Methicillin susceptible Staphylococcus aureus
  • A41.02Sepsis due to Methicillin resistant Staphylococcus aureus
  • A41.1Sepsis due to other specified staphylococcus
  • A41.2Sepsis due to unspecified staphylococcus
  • A41.3Sepsis due to Hemophilus influenzae
  • A41.4Sepsis due to anaerobes
  • A41.50Gram-negative sepsis, unspecified
  • A41.51Sepsis due to Escherichia coli [E. coli]
  • A41.52Sepsis due to Pseudomonas
  • A41.53Sepsis due to Serratia
  • A41.59Other Gram-negative sepsis
  • A41.81Sepsis due to Enterococcus
  • A41.89Other specified sepsis
  • A41.9Sepsis, unspecified organism
  • A42.7Actinomycotic sepsis
  • A52.01Syphilitic aneurysm of aorta
  • A52.02Syphilitic aortitis
  • A52.03Syphilitic endocarditis
  • A52.06Other syphilitic heart involvement
  • A54.83Gonococcal heart infection
  • A69.21Meningitis due to Lyme disease
  • A69.22Other neurologic disorders in Lyme disease
  • A69.23Arthritis due to Lyme disease
  • A69.29Other conditions associated with Lyme disease
  • B33.20Viral carditis, unspecified
  • B33.21Viral endocarditis
  • B33.22Viral myocarditis
  • B33.23Viral pericarditis
  • B37.6Candidal endocarditis
  • B39.4*Histoplasmosis capsulati, unspecified
  • B39.5*Histoplasmosis duboisii
  • B57.0Acute Chagas' disease with heart involvement
  • B57.2Chagas' disease (chronic) with heart involvement
  • B58.81Toxoplasma myocarditis
  • C38.0Malignant neoplasm of heart
  • C45.2Mesothelioma of pericardium
  • C79.89Secondary malignant neoplasm of other specified sites
  • D15.1Benign neoplasm of heart
  • D48.7Neoplasm of uncertain behavior of other specified sites
  • D49.89Neoplasm of unspecified behavior of other specified sites
  • D86.0Sarcoidosis of lung
  • D86.1Sarcoidosis of lymph nodes
  • D86.2Sarcoidosis of lung with sarcoidosis of lymph nodes
  • D86.3Sarcoidosis of skin
  • D86.81Sarcoid meningitis
  • D86.82Multiple cranial nerve palsies in sarcoidosis
  • D86.83Sarcoid iridocyclitis
  • D86.84Sarcoid pyelonephritis
  • D86.85Sarcoid myocarditis
  • D86.86Sarcoid arthropathy
  • D86.87Sarcoid myositis
  • D86.89Sarcoidosis of other sites
  • E03.5Myxedema coma
  • E83.110Hereditary hemochromatosis
  • E83.111Hemochromatosis due to repeated red blood cell transfusions
  • E83.118Other hemochromatosis
  • E83.19Other disorders of iron metabolism
  • E85.0Non-neuropathic heredofamilial amyloidosis
  • E85.1Neuropathic heredofamilial amyloidosis
  • E85.2Heredofamilial amyloidosis, unspecified
  • E85.3Secondary systemic amyloidosis
  • E85.4Organ-limited amyloidosis
  • E85.81Light chain (AL) amyloidosis
  • E85.82Wild-type transthyretin-related (ATTR) amyloidosis
  • E85.89Other amyloidosis
  • E85.9Amyloidosis, unspecified
  • G06.0Intracranial abscess and granuloma
  • G06.1Intraspinal abscess and granuloma
  • G45.0Vertebro-basilar artery syndrome
  • G45.1Carotid artery syndrome (hemispheric)
  • G45.2Multiple and bilateral precerebral artery syndromes
  • G45.3Amaurosis fugax
  • G45.8Other transient cerebral ischemic attacks and related syndromes
  • G45.9Transient cerebral ischemic attack, unspecified
  • G46.0Middle cerebral artery syndrome
  • G46.1Anterior cerebral artery syndrome
  • G46.2Posterior cerebral artery syndrome
  • G47.30Sleep apnea, unspecified
  • G47.31Primary central sleep apnea
  • G47.32High altitude periodic breathing
  • G47.33Obstructive sleep apnea (adult) (pediatric)
  • H34.01Transient retinal artery occlusion, right eye
  • H34.02Transient retinal artery occlusion, left eye
  • H34.03Transient retinal artery occlusion, bilateral
  • I01.0Acute rheumatic pericarditis
  • I01.1Acute rheumatic endocarditis
  • I01.2Acute rheumatic myocarditis
  • I01.8Other acute rheumatic heart disease
  • I01.9Acute rheumatic heart disease, unspecified
  • I02.0Rheumatic chorea with heart involvement
  • I02.9Rheumatic chorea without heart involvement
  • I05.0Rheumatic mitral stenosis
  • I05.1Rheumatic mitral insufficiency
  • I05.2Rheumatic mitral stenosis with insufficiency
  • I05.8Other rheumatic mitral valve diseases
  • I06.0Rheumatic aortic stenosis
  • I06.1Rheumatic aortic insufficiency
  • I06.2Rheumatic aortic stenosis with insufficiency
  • I06.8Other rheumatic aortic valve diseases
  • I07.0Rheumatic tricuspid stenosis
  • I07.1Rheumatic tricuspid insufficiency
  • I07.2Rheumatic tricuspid stenosis and insufficiency
  • I07.8Other rheumatic tricuspid valve diseases
  • I08.0Rheumatic disorders of both mitral and aortic valves
  • I08.1Rheumatic disorders of both mitral and tricuspid valves
  • I08.2Rheumatic disorders of both aortic and tricuspid valves
  • I08.3Combined rheumatic disorders of mitral, aortic and tricuspid valves
  • I08.8Other rheumatic multiple valve diseases
  • I08.9Rheumatic multiple valve disease, unspecified
  • I09.0Rheumatic myocarditis
  • I09.1Rheumatic diseases of endocardium, valve unspecified
  • I09.2Chronic rheumatic pericarditis
  • I09.81Rheumatic heart failure
  • I09.89Other specified rheumatic heart diseases
  • I11.0Hypertensive heart disease with heart failure
  • I13.0Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
  • I13.11Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease
  • I13.2Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease
  • I15.0Renovascular hypertension
  • I15.1Hypertension secondary to other renal disorders
  • I20.0Unstable angina
  • I20.1Angina pectoris with documented spasm
  • I20.81Angina pectoris with coronary microvascular dysfunction
  • I20.89Other forms of angina pectoris
  • I21.01ST elevation (STEMI) myocardial infarction involving left main coronary artery
  • I21.02ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery
  • I21.09ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall
  • I21.11ST elevation (STEMI) myocardial infarction involving right coronary artery
  • I21.19ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall
  • I21.21ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery
  • I21.29ST elevation (STEMI) myocardial infarction involving other sites
  • I21.3ST elevation (STEMI) myocardial infarction of unspecified site
  • I21.4Non-ST elevation (NSTEMI) myocardial infarction
  • I21.A1Myocardial infarction type 2
  • I21.A9Other myocardial infarction type
  • I22.0Subsequent ST elevation (STEMI) myocardial infarction of anterior wall
  • I22.1Subsequent ST elevation (STEMI) myocardial infarction of inferior wall
  • I22.2Subsequent non-ST elevation (NSTEMI) myocardial infarction
  • I22.8Subsequent ST elevation (STEMI) myocardial infarction of other sites
  • I22.9Subsequent ST elevation (STEMI) myocardial infarction of unspecified site
  • I23.0Hemopericardium as current complication following acute myocardial infarction
  • I23.1Atrial septal defect as current complication following acute myocardial infarction
  • I23.2Ventricular septal defect as current complication following acute myocardial infarction
  • I23.3Rupture of cardiac wall without hemopericardium as current complication following acute myocardial infarction
  • I23.4Rupture of chordae tendineae as current complication following acute myocardial infarction
  • I23.5Rupture of papillary muscle as current complication following acute myocardial infarction
  • I23.6Thrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction
  • I23.7Postinfarction angina
  • I23.8Other current complications following acute myocardial infarction
  • I24.0Acute coronary thrombosis not resulting in myocardial infarction
  • I24.1Dressler's syndrome
  • I24.81Acute coronary microvascular dysfunction
  • I24.89Other forms of acute ischemic heart disease
  • I25.10Atherosclerotic heart disease of native coronary artery without angina pectoris
  • I25.110Atherosclerotic heart disease of native coronary artery with unstable angina pectoris
  • I25.111Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm
  • I25.112Atherosclerotic heart disease of native coronary artery with refractory angina pectoris
  • I25.118Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris
  • I25.2Old myocardial infarction
  • I25.3Aneurysm of heart
  • I25.41Coronary artery aneurysm
  • I25.42Coronary artery dissection
  • I25.5Ischemic cardiomyopathy
  • I25.6Silent myocardial ischemia
  • I25.702Atherosclerosis of coronary artery bypass graft(s), unspecified, with refractory angina pectoris
  • I25.710Atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris
  • I25.711Atherosclerosis of autologous vein coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.712Atherosclerosis of autologous vein coronary artery bypass graft(s) with refractory angina pectoris
  • I25.718Atherosclerosis of autologous vein coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.720Atherosclerosis of autologous artery coronary artery bypass graft(s) with unstable angina pectoris
  • I25.721Atherosclerosis of autologous artery coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.722Atherosclerosis of autologous artery coronary artery bypass graft(s) with refractory angina pectoris
  • I25.728Atherosclerosis of autologous artery coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.730Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unstable angina pectoris
  • I25.731Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.732Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with refractory angina pectoris
  • I25.738Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.750Atherosclerosis of native coronary artery of transplanted heart with unstable angina
  • I25.751Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm
  • I25.752Atherosclerosis of native coronary artery of transplanted heart with refractory angina pectoris
  • I25.758Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris
  • I25.760Atherosclerosis of bypass graft of coronary artery of transplanted heart with unstable angina
  • I25.761Atherosclerosis of bypass graft of coronary artery of transplanted heart with angina pectoris with documented spasm
  • I25.762Atherosclerosis of bypass graft of coronary artery of transplanted heart with refractory angina pectoris
  • I25.768Atherosclerosis of bypass graft of coronary artery of transplanted heart with other forms of angina pectoris
  • I25.790Atherosclerosis of other coronary artery bypass graft(s) with unstable angina pectoris
  • I25.791Atherosclerosis of other coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.792Atherosclerosis of other coronary artery bypass graft(s) with refractory angina pectoris
  • I25.798Atherosclerosis of other coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.810Atherosclerosis of coronary artery bypass graft(s) without angina pectoris
  • I25.811Atherosclerosis of native coronary artery of transplanted heart without angina pectoris
  • I25.812Atherosclerosis of bypass graft of coronary artery of transplanted heart without angina pectoris
  • I25.82Chronic total occlusion of coronary artery
  • I25.84Coronary atherosclerosis due to calcified coronary lesion
  • I25.89Other forms of chronic ischemic heart disease
  • I26.01Septic pulmonary embolism with acute cor pulmonale
  • I26.02Saddle embolus of pulmonary artery with acute cor pulmonale
  • I26.03Cement embolism of pulmonary artery with acute cor pulmonale
  • I26.04Fat embolism of pulmonary artery with acute cor pulmonale
  • I26.09Other pulmonary embolism with acute cor pulmonale
  • I26.90Septic pulmonary embolism without acute cor pulmonale
  • I26.92Saddle embolus of pulmonary artery without acute cor pulmonale
  • I26.93Single subsegmental thrombotic pulmonary embolism without acute cor pulmonale
  • I26.94Multiple subsegmental thrombotic pulmonary emboli without acute cor pulmonale
  • I26.95Cement embolism of pulmonary artery without acute cor pulmonale
  • I26.96Fat embolism of pulmonary artery without acute cor pulmonale
  • I26.99Other pulmonary embolism without acute cor pulmonale
  • I27.0Primary pulmonary hypertension
  • I27.1Kyphoscoliotic heart disease
  • I27.20Pulmonary hypertension, unspecified
  • I27.21Secondary pulmonary arterial hypertension
  • I27.22Pulmonary hypertension due to left heart disease
  • I27.23Pulmonary hypertension due to lung diseases and hypoxia
  • I27.24Chronic thromboembolic pulmonary hypertension
  • I27.29Other secondary pulmonary hypertension
  • I27.82Chronic pulmonary embolism
  • I27.83Eisenmenger's syndrome
  • I27.840Fontan-associated liver disease [FALD]
  • I27.841Fontan-associated lymphatic dysfunction
  • I27.848Other Fontan-associated condition
  • I27.89Other specified pulmonary heart diseases
  • I28.0Arteriovenous fistula of pulmonary vessels
  • I28.1Aneurysm of pulmonary artery
  • I30.0Acute nonspecific idiopathic pericarditis
  • I30.1Infective pericarditis
  • I30.8Other forms of acute pericarditis
  • I31.0Chronic adhesive pericarditis
  • I31.1Chronic constrictive pericarditis
  • I31.2Hemopericardium, not elsewhere classified
  • I31.31Malignant pericardial effusion in diseases classified elsewhere
  • I31.39Other pericardial effusion (noninflammatory)
  • I31.4Cardiac tamponade
  • I31.8Other specified diseases of pericardium
  • I32Pericarditis in diseases classified elsewhere
  • I33.0Acute and subacute infective endocarditis
  • I33.9Acute and subacute endocarditis, unspecified
  • I34.0Nonrheumatic mitral (valve) insufficiency
  • I34.1Nonrheumatic mitral (valve) prolapse
  • I34.2Nonrheumatic mitral (valve) stenosis
  • I34.81Nonrheumatic mitral (valve) annulus calcification
  • I34.89Other nonrheumatic mitral valve disorders
  • I35.0Nonrheumatic aortic (valve) stenosis
  • I35.1Nonrheumatic aortic (valve) insufficiency
  • I35.2Nonrheumatic aortic (valve) stenosis with insufficiency
  • I35.8Other nonrheumatic aortic valve disorders
  • I36.0Nonrheumatic tricuspid (valve) stenosis
  • I36.1Nonrheumatic tricuspid (valve) insufficiency
  • I36.2Nonrheumatic tricuspid (valve) stenosis with insufficiency
  • I36.8Other nonrheumatic tricuspid valve disorders
  • I37.0Nonrheumatic pulmonary valve stenosis
  • I37.1Nonrheumatic pulmonary valve insufficiency
  • I37.2Nonrheumatic pulmonary valve stenosis with insufficiency
  • I37.8Other nonrheumatic pulmonary valve disorders
  • I38Endocarditis, valve unspecified
  • I39Endocarditis and heart valve disorders in diseases classified elsewhere
  • I40.0Infective myocarditis
  • I40.1Isolated myocarditis
  • I40.8Other acute myocarditis
  • I40.9Acute myocarditis, unspecified
  • I41Myocarditis in diseases classified elsewhere
  • I42.00Dilated cardiomyopathy, unspecified
  • I42.01Familial-genetic dilated cardiomyopathy
  • I42.09Other dilated cardiomyopathy
  • I42.1Obstructive hypertrophic cardiomyopathy
  • I42.2Other hypertrophic cardiomyopathy
  • I42.3Endomyocardial (eosinophilic) disease
  • I42.4Endocardial fibroelastosis
  • I42.5Other restrictive cardiomyopathy
  • I42.6Alcoholic cardiomyopathy
  • I42.7Cardiomyopathy due to drug and external agent
  • I42.81Arrhythmogenic cardiomyopathy
  • I42.89Other cardiomyopathies not elsewhere classified
  • I43Cardiomyopathy in diseases classified elsewhere
  • I44.1Atrioventricular block, second degree
  • I44.2Atrioventricular block, complete
  • I44.30Unspecified atrioventricular block
  • I44.39Other atrioventricular block
  • I44.7Left bundle-branch block, unspecified
  • I45.2Bifascicular block
  • I45.3Trifascicular block
  • I45.4Nonspecific intraventricular block
  • I45.5Other specified heart block
  • I45.6Pre-excitation syndrome
  • I45.9Conduction disorder, unspecified
  • I46.2Cardiac arrest due to underlying cardiac condition
  • I46.8Cardiac arrest due to other underlying condition
  • I46.9Cardiac arrest, cause unspecified
  • I47.0Re-entry ventricular arrhythmia
  • I47.11Inappropriate sinus tachycardia, so stated
  • I47.19Other supraventricular tachycardia
  • I47.21Torsades de pointes
  • I47.29Other ventricular tachycardia
  • I47.9Paroxysmal tachycardia, unspecified
  • I48.0Paroxysmal atrial fibrillation
  • I48.11Longstanding persistent atrial fibrillation
  • I48.19Other persistent atrial fibrillation
  • I48.20Chronic atrial fibrillation, unspecified
  • I48.21Permanent atrial fibrillation
  • I48.3Typical atrial flutter
  • I48.4Atypical atrial flutter
  • I49.01Ventricular fibrillation
  • I49.02Ventricular flutter
  • I49.1Atrial premature depolarization
  • I49.2Junctional premature depolarization
  • I49.3Ventricular premature depolarization
  • I49.40Unspecified premature depolarization
  • I49.49Other premature depolarization
  • I50.1Left ventricular failure, unspecified
  • I50.21Acute systolic (congestive) heart failure
  • I50.22Chronic systolic (congestive) heart failure
  • I50.23Acute on chronic systolic (congestive) heart failure
  • I50.31Acute diastolic (congestive) heart failure
  • I50.32Chronic diastolic (congestive) heart failure
  • I50.33Acute on chronic diastolic (congestive) heart failure
  • I50.41Acute combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.42Chronic combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.43Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure
  • I51.0Cardiac septal defect, acquired
  • I51.1Rupture of chordae tendineae, not elsewhere classified
  • I51.2Rupture of papillary muscle, not elsewhere classified
  • I51.3Intracardiac thrombosis, not elsewhere classified
  • I51.4Myocarditis, unspecified
  • I51.5Myocardial degeneration
  • I51.7Cardiomegaly
  • I51.81Takotsubo syndrome
  • I51.89Other ill-defined heart diseases
  • I51.9Heart disease, unspecified
  • I52Other heart disorders in diseases classified elsewhere
  • I60.01Nontraumatic subarachnoid hemorrhage from right carotid siphon and bifurcation
  • I60.02Nontraumatic subarachnoid hemorrhage from left carotid siphon and bifurcation
  • I60.11Nontraumatic subarachnoid hemorrhage from right middle cerebral artery
  • I60.12Nontraumatic subarachnoid hemorrhage from left middle cerebral artery
  • I60.31Nontraumatic subarachnoid hemorrhage from right posterior communicating artery
  • I60.32Nontraumatic subarachnoid hemorrhage from left posterior communicating artery
  • I60.4Nontraumatic subarachnoid hemorrhage from basilar artery
  • I60.51Nontraumatic subarachnoid hemorrhage from right vertebral artery
  • I60.52Nontraumatic subarachnoid hemorrhage from left vertebral artery
  • I60.6Nontraumatic subarachnoid hemorrhage from other intracranial arteries
  • I60.7Nontraumatic subarachnoid hemorrhage from unspecified intracranial artery
  • I60.8Other nontraumatic subarachnoid hemorrhage
  • I63.311Cerebral infarction due to thrombosis of right middle cerebral artery
  • I63.312Cerebral infarction due to thrombosis of left middle cerebral artery
  • I63.321Cerebral infarction due to thrombosis of right anterior cerebral artery
  • I63.322Cerebral infarction due to thrombosis of left anterior cerebral artery
  • I63.331Cerebral infarction due to thrombosis of right posterior cerebral artery
  • I63.332Cerebral infarction due to thrombosis of left posterior cerebral artery
  • I63.341Cerebral infarction due to thrombosis of right cerebellar artery
  • I63.342Cerebral infarction due to thrombosis of left cerebellar artery
  • I63.39Cerebral infarction due to thrombosis of other cerebral artery
  • I63.411Cerebral infarction due to embolism of right middle cerebral artery
  • I63.412Cerebral infarction due to embolism of left middle cerebral artery
  • I63.421Cerebral infarction due to embolism of right anterior cerebral artery
  • I63.422Cerebral infarction due to embolism of left anterior cerebral artery
  • I63.431Cerebral infarction due to embolism of right posterior cerebral artery
  • I63.432Cerebral infarction due to embolism of left posterior cerebral artery
  • I63.441Cerebral infarction due to embolism of right cerebellar artery
  • I63.442Cerebral infarction due to embolism of left cerebellar artery
  • I63.49Cerebral infarction due to embolism of other cerebral artery
  • I63.511Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery
  • I63.512Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery
  • I63.521Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery
  • I63.522Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery
  • I63.531Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery
  • I63.532Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery
  • I63.541Cerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery
  • I63.542Cerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery
  • I63.59Cerebral infarction due to unspecified occlusion or stenosis of other cerebral artery
  • I63.6Cerebral infarction due to cerebral venous thrombosis, nonpyogenic
  • I63.81Other cerebral infarction due to occlusion or stenosis of small artery
  • I63.89Other cerebral infarction
  • I66.01Occlusion and stenosis of right middle cerebral artery
  • I66.02Occlusion and stenosis of left middle cerebral artery
  • I66.03Occlusion and stenosis of bilateral middle cerebral arteries
  • I66.11Occlusion and stenosis of right anterior cerebral artery
  • I66.12Occlusion and stenosis of left anterior cerebral artery
  • I66.13Occlusion and stenosis of bilateral anterior cerebral arteries
  • I66.21Occlusion and stenosis of right posterior cerebral artery
  • I66.22Occlusion and stenosis of left posterior cerebral artery
  • I66.23Occlusion and stenosis of bilateral posterior cerebral arteries
  • I66.3Occlusion and stenosis of cerebellar arteries
  • I66.8Occlusion and stenosis of other cerebral arteries
  • I67.841Reversible cerebrovascular vasoconstriction syndrome
  • I67.848Other cerebrovascular vasospasm and vasoconstriction
  • I67.850Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
  • I67.858Other hereditary cerebrovascular disease
  • I67.89Other cerebrovascular disease
  • I70.0Atherosclerosis of aorta
  • I71.00Dissection of unspecified site of aorta
  • I71.010Dissection of ascending aorta
  • I71.011Dissection of aortic arch
  • I71.012Dissection of descending thoracic aorta
  • I71.019Dissection of thoracic aorta, unspecified
  • I71.02Dissection of abdominal aorta
  • I71.03Dissection of thoracoabdominal aorta
  • I71.11Aneurysm of the ascending aorta, ruptured
  • I71.12Aneurysm of the aortic arch, ruptured
  • I71.13Aneurysm of the descending thoracic aorta, ruptured
  • I71.21Aneurysm of the ascending aorta, without rupture
  • I71.22Aneurysm of the aortic arch, without rupture
  • I71.23Aneurysm of the descending thoracic aorta, without rupture
  • I71.31Pararenal abdominal aortic aneurysm, ruptured
  • I71.32Juxtarenal abdominal aortic aneurysm, ruptured
  • I71.33Infrarenal abdominal aortic aneurysm, ruptured
  • I71.41Pararenal abdominal aortic aneurysm, without rupture
  • I71.42Juxtarenal abdominal aortic aneurysm, without rupture
  • I71.43Infrarenal abdominal aortic aneurysm, without rupture
  • I71.51Supraceliac aneurysm of the thoracoabdominal aorta, ruptured
  • I71.52Paravisceral aneurysm of the thoracoabdominal aorta, ruptured
  • I71.61Supraceliac aneurysm of the thoracoabdominal aorta, without rupture
  • I71.62Paravisceral aneurysm of the thoracoabdominal aorta, without rupture
  • I71.8Aortic aneurysm of unspecified site, ruptured
  • I74.11Embolism and thrombosis of thoracic aorta
  • I74.2Embolism and thrombosis of arteries of the upper extremities
  • I74.3Embolism and thrombosis of arteries of the lower extremities
  • I74.4Embolism and thrombosis of arteries of extremities, unspecified
  • I74.5Embolism and thrombosis of iliac artery
  • I74.8Embolism and thrombosis of other arteries
  • I74.9Embolism and thrombosis of unspecified artery
  • I76Septic arterial embolism
  • I77.810Thoracic aortic ectasia
  • I79.0Aneurysm of aorta in diseases classified elsewhere
  • I95.1Orthostatic hypotension
  • I95.2Hypotension due to drugs
  • I95.81Postprocedural hypotension
  • I95.89Other hypotension
  • I95.9Hypotension, unspecified
  • I97.0Postcardiotomy syndrome
  • I97.110Postprocedural cardiac insufficiency following cardiac surgery
  • I97.111Postprocedural cardiac insufficiency following other surgery
  • I97.120Postprocedural cardiac arrest following cardiac surgery
  • I97.121Postprocedural cardiac arrest following other surgery
  • I97.130Postprocedural heart failure following cardiac surgery
  • I97.131Postprocedural heart failure following other surgery
  • I97.190Other postprocedural cardiac functional disturbances following cardiac surgery
  • I97.191Other postprocedural cardiac functional disturbances following other surgery
  • I97.710Intraoperative cardiac arrest during cardiac surgery
  • I97.711Intraoperative cardiac arrest during other surgery
  • I97.790Other intraoperative cardiac functional disturbances during cardiac surgery
  • I97.791Other intraoperative cardiac functional disturbances during other surgery
  • I97.88Other intraoperative complications of the circulatory system, not elsewhere classified
  • I97.89Other postprocedural complications and disorders of the circulatory system, not elsewhere classified
  • J80Acute respiratory distress syndrome
  • J81.0Acute pulmonary edema
  • J95.1Acute pulmonary insufficiency following thoracic surgery
  • J95.2Acute pulmonary insufficiency following nonthoracic surgery
  • J95.3Chronic pulmonary insufficiency following surgery
  • J95.821Acute postprocedural respiratory failure
  • J95.822Acute and chronic postprocedural respiratory failure
  • J95.84Transfusion-related acute lung injury (TRALI)
  • J96.01Acute respiratory failure with hypoxia
  • J96.02Acute respiratory failure with hypercapnia
  • J96.21Acute and chronic respiratory failure with hypoxia
  • J96.22Acute and chronic respiratory failure with hypercapnia
  • K68.11Postprocedural retroperitoneal abscess
  • M30.3Mucocutaneous lymph node syndrome [Kawasaki]
  • M31.4Aortic arch syndrome [Takayasu]
  • M32.0Drug-induced systemic lupus erythematosus
  • M32.11Endocarditis in systemic lupus erythematosus
  • M32.12Pericarditis in systemic lupus erythematosus
  • M32.13Lung involvement in systemic lupus erythematosus
  • M32.14Glomerular disease in systemic lupus erythematosus
  • M32.15Tubulo-interstitial nephropathy in systemic lupus erythematosus
  • M32.19Other organ or system involvement in systemic lupus erythematosus
  • M32.8Other forms of systemic lupus erythematosus
  • M32.9Systemic lupus erythematosus, unspecified
  • N26.2Page kidney
  • N98.0Infection associated with artificial insemination
  • O90.3Peripartum cardiomyopathy
  • O90.89Other complications of the puerperium, not elsewhere classified
  • Q20.2Double outlet left ventricle
  • Q20.3Discordant ventriculoarterial connection
  • Q20.5Discordant atrioventricular connection
  • Q20.8Other congenital malformations of cardiac chambers and connections
  • Q21.0Ventricular septal defect
  • Q21.11Secundum atrial septal defect
  • Q21.12Patent foramen ovale
  • Q21.13Coronary sinus atrial septal defect
  • Q21.14Superior sinus venosus atrial septal defect
  • Q21.15Inferior sinus venosus atrial septal defect
  • Q21.19Other specified atrial septal defect
  • Q21.20Atrioventricular septal defect, unspecified as to partial or complete
  • Q21.21Partial atrioventricular septal defect
  • Q21.22Transitional atrioventricular septal defect
  • Q21.23Complete atrioventricular septal defect
  • Q21.3Tetralogy of Fallot
  • Q21.4Aortopulmonary septal defect
  • Q21.9Congenital malformation of cardiac septum, unspecified
  • Q22.1Congenital pulmonary valve stenosis
  • Q22.2Congenital pulmonary valve insufficiency
  • Q22.3Other congenital malformations of pulmonary valve
  • Q22.4Congenital tricuspid stenosis
  • Q22.5Ebstein's anomaly
  • Q22.6Hypoplastic right heart syndrome
  • Q22.8Other congenital malformations of tricuspid valve
  • Q23.0Congenital stenosis of aortic valve
  • Q23.1Congenital insufficiency of aortic valve
  • Q23.2Congenital mitral stenosis
  • Q23.3Congenital mitral insufficiency
  • Q23.81Bicuspid aortic valve
  • Q23.82Congenital mitral valve cleft leaflet
  • Q23.88Other congenital malformations of aortic and mitral valves
  • Q24.0Dextrocardia
  • Q24.1Levocardia
  • Q24.2Cor triatriatum
  • Q24.3Pulmonary infundibular stenosis
  • Q24.4Congenital subaortic stenosis
  • Q24.6Congenital heart block
  • Q24.8Other specified congenital malformations of heart
  • Q25.0Patent ductus arteriosus
  • Q25.1Coarctation of aorta
  • Q25.21Interruption of aortic arch
  • Q25.29Other atresia of aorta
  • Q25.3Supravalvular aortic stenosis
  • Q25.41Absence and aplasia of aorta
  • Q25.42Hypoplasia of aorta
  • Q25.43Congenital aneurysm of aorta
  • Q25.44Congenital dilation of aorta
  • Q25.45Double aortic arch
  • Q25.46Tortuous aortic arch
  • Q25.47Right aortic arch
  • Q25.48Anomalous origin of subclavian artery
  • Q25.49Other congenital malformations of aorta
  • Q25.5Atresia of pulmonary artery
  • Q25.6Stenosis of pulmonary artery
  • Q25.71Coarctation of pulmonary artery
  • Q25.72Congenital pulmonary arteriovenous malformation
  • Q25.79Other congenital malformations of pulmonary artery
  • Q25.8Other congenital malformations of other great arteries
  • Q26.0Congenital stenosis of vena cava
  • Q26.1Persistent left superior vena cava
  • Q26.2Total anomalous pulmonary venous connection
  • Q26.3Partial anomalous pulmonary venous connection
  • Q26.4Anomalous pulmonary venous connection, unspecified
  • Q26.8Other congenital malformations of great veins
  • Q26.9Congenital malformation of great vein, unspecified
  • Q27.9Congenital malformation of peripheral vascular system, unspecified
  • Q28.2Arteriovenous malformation of cerebral vessels
  • Q28.3Other malformations of cerebral vessels
  • Q87.410Marfan syndrome with aortic dilation
  • Q87.418Marfan syndrome with other cardiovascular manifestations
  • Q87.42Marfan syndrome with ocular manifestations
  • Q87.43Marfan syndrome with skeletal manifestation
  • Q89.01Asplenia (congenital)
  • Q89.09Congenital malformations of spleen
  • Q89.3Situs inversus
  • Q89.9Congenital malformation, unspecified
  • Q90.0Trisomy 21, nonmosaicism (meiotic nondisjunction)
  • Q90.1Trisomy 21, mosaicism (mitotic nondisjunction)
  • Q90.2Trisomy 21, translocation
  • Q96.0Karyotype 45, X
  • Q96.1Karyotype 46, X iso (Xq)
  • Q96.2Karyotype 46, X with abnormal sex chromosome, except iso (Xq)
  • Q96.3Mosaicism, 45, X/46, XX or XY
  • Q96.4Mosaicism, 45, X/other cell line(s) with abnormal sex chromosome
  • Q96.8Other variants of Turner's syndrome
  • R00.2Palpitations
  • R00.8Other abnormalities of heart beat
  • R01.0Benign and innocent cardiac murmurs
  • R01.1Cardiac murmur, unspecified
  • R01.2Other cardiac sounds
  • R06.00Dyspnea, unspecified
  • R06.02Shortness of breath
  • R06.09Other forms of dyspnea
  • R06.2Wheezing
  • R06.3Periodic breathing
  • R06.81Apnea, not elsewhere classified
  • R06.82Tachypnea, not elsewhere classified
  • R06.83Snoring
  • R06.89Other abnormalities of breathing
  • R07.2Precordial pain
  • R07.82Intercostal pain
  • R07.89Other chest pain
  • R07.9Chest pain, unspecified
  • R09.2Respiratory arrest
  • R22.2Localized swelling, mass and lump, trunk
  • R23.0Cyanosis
  • R40.20Unspecified coma
  • R40.2111Coma scale, eyes open, never, in the field [EMT or ambulance]
  • R40.2112Coma scale, eyes open, never, at arrival to emergency department
  • R40.2113Coma scale, eyes open, never, at hospital admission
  • R40.2114Coma scale, eyes open, never, 24 hours or more after hospital admission
  • R40.2121Coma scale, eyes open, to pain, in the field [EMT or ambulance]
  • R40.2122Coma scale, eyes open, to pain, at arrival to emergency department
  • R40.2123Coma scale, eyes open, to pain, at hospital admission
  • R40.2124Coma scale, eyes open, to pain, 24 hours or more after hospital admission
  • R40.2211Coma scale, best verbal response, none, in the field [EMT or ambulance]
  • R40.2212Coma scale, best verbal response, none, at arrival to emergency department
  • R40.2213Coma scale, best verbal response, none, at hospital admission
  • R40.2214Coma scale, best verbal response, none, 24 hours or more after hospital admission
  • R40.2221Coma scale, best verbal response, incomprehensible words, in the field [EMT or ambulance]
  • R40.2222Coma scale, best verbal response, incomprehensible words, at arrival to emergency department
  • R40.2223Coma scale, best verbal response, incomprehensible words, at hospital admission
  • R40.2224Coma scale, best verbal response, incomprehensible words, 24 hours or more after hospital admission
  • R40.2311Coma scale, best motor response, none, in the field [EMT or ambulance]
  • R40.2312Coma scale, best motor response, none, at arrival to emergency department
  • R40.2313Coma scale, best motor response, none, at hospital admission
  • R40.2314Coma scale, best motor response, none, 24 hours or more after hospital admission
  • R40.2321Coma scale, best motor response, extension, in the field [EMT or ambulance]
  • R40.2322Coma scale, best motor response, extension, at arrival to emergency department
  • R40.2323Coma scale, best motor response, extension, at hospital admission
  • R40.2324Coma scale, best motor response, extension, 24 hours or more after hospital admission
  • R40.2341Coma scale, best motor response, flexion withdrawal, in the field [EMT or ambulance]
  • R40.2342Coma scale, best motor response, flexion withdrawal, at arrival to emergency department
  • R40.2343Coma scale, best motor response, flexion withdrawal, at hospital admission
  • R40.2344Coma scale, best motor response, flexion withdrawal, 24 hours or more after hospital admission
  • R40.4Transient alteration of awareness
  • R47.01Aphasia
  • R50.2Drug induced fever
  • R50.81Fever presenting with conditions classified elsewhere
  • R50.82Postprocedural fever
  • R50.9Fever, unspecified
  • R55Syncope and collapse
  • R57.0Cardiogenic shock
  • R57.1Hypovolemic shock
  • R57.8Other shock
  • R57.9Shock, unspecified
  • R60.0Localized edema
  • R60.1Generalized edema
  • R65.21Severe sepsis with septic shock
  • R68.89Other general symptoms and signs
  • R78.81Bacteremia
  • R94.31Abnormal electrocardiogram [ECG] [EKG]
  • S12.000B*Unspecified displaced fracture of first cervical vertebra, initial encounter for open fracture
  • S12.001B*Unspecified nondisplaced fracture of first cervical vertebra, initial encounter for open fracture
  • S12.100B*Unspecified displaced fracture of second cervical vertebra, initial encounter for open fracture
  • S12.101B*Unspecified nondisplaced fracture of second cervical vertebra, initial encounter for open fracture
  • S12.200B*Unspecified displaced fracture of third cervical vertebra, initial encounter for open fracture
  • S12.201B*Unspecified nondisplaced fracture of third cervical vertebra, initial encounter for open fracture
  • S12.300B*Unspecified displaced fracture of fourth cervical vertebra, initial encounter for open fracture
  • S12.301B*Unspecified nondisplaced fracture of fourth cervical vertebra, initial encounter for open fracture
  • S14.111A*Complete lesion at C1 level of cervical spinal cord, initial encounter
  • S14.112A*Complete lesion at C2 level of cervical spinal cord, initial encounter
  • S14.113A*Complete lesion at C3 level of cervical spinal cord, initial encounter
  • S14.114A*Complete lesion at C4 level of cervical spinal cord, initial encounter
  • S14.121A*Central cord syndrome at C1 level of cervical spinal cord, initial encounter
  • S14.122A*Central cord syndrome at C2 level of cervical spinal cord, initial encounter
  • S14.123A*Central cord syndrome at C3 level of cervical spinal cord, initial encounter
  • S14.124A*Central cord syndrome at C4 level of cervical spinal cord, initial encounter
  • S21.309A*Unspecified open wound of unspecified front wall of thorax with penetration into thoracic cavity, initial encounter
  • S22.5XXAFlail chest, initial encounter for closed fracture
  • S22.5XXBFlail chest, initial encounter for open fracture
  • S25.01XAMinor laceration of thoracic aorta, initial encounter
  • S25.02XAMajor laceration of thoracic aorta, initial encounter
  • S25.09XAOther specified injury of thoracic aorta, initial encounter
  • S25.21XAMinor laceration of superior vena cava, initial encounter
  • S25.22XAMajor laceration of superior vena cava, initial encounter
  • S25.29XAOther specified injury of superior vena cava, initial encounter
  • S25.401AUnspecified injury of right pulmonary blood vessels, initial encounter
  • S25.402AUnspecified injury of left pulmonary blood vessels, initial encounter
  • S25.411AMinor laceration of right pulmonary blood vessels, initial encounter
  • S25.412AMinor laceration of left pulmonary blood vessels, initial encounter
  • S25.421AMajor laceration of right pulmonary blood vessels, initial encounter
  • S25.422AMajor laceration of left pulmonary blood vessels, initial encounter
  • S25.491AOther specified injury of right pulmonary blood vessels, initial encounter
  • S25.492AOther specified injury of left pulmonary blood vessels, initial encounter
  • S26.00XAUnspecified injury of heart with hemopericardium, initial encounter
  • S26.01XAContusion of heart with hemopericardium, initial encounter
  • S26.020AMild laceration of heart with hemopericardium, initial encounter
  • S26.021AModerate laceration of heart with hemopericardium, initial encounter
  • S26.022AMajor laceration of heart with hemopericardium, initial encounter
  • S26.09XAOther injury of heart with hemopericardium, initial encounter
  • S26.10XAUnspecified injury of heart without hemopericardium, initial encounter
  • S26.11XAContusion of heart without hemopericardium, initial encounter
  • S26.12XALaceration of heart without hemopericardium, initial encounter
  • S26.19XAOther injury of heart without hemopericardium, initial encounter
  • S26.90XA*Unspecified injury of heart, unspecified with or without hemopericardium, initial encounter
  • S26.92XA*Laceration of heart, unspecified with or without hemopericardium, initial encounter
  • S29.091AOther injury of muscle and tendon of front wall of thorax, initial encounter
  • S29.092AOther injury of muscle and tendon of back wall of thorax, initial encounter
  • S29.8XXAOther specified injuries of thorax, initial encounter
  • T36.0X5AAdverse effect of penicillins, initial encounter
  • T36.1X5AAdverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter
  • T36.2X5AAdverse effect of chloramphenicol group, initial encounter
  • T36.3X5AAdverse effect of macrolides, initial encounter
  • T36.4X5AAdverse effect of tetracyclines, initial encounter
  • T36.5X5AAdverse effect of aminoglycosides, initial encounter
  • T36.6X5AAdverse effect of rifampicins, initial encounter
  • T36.7X5AAdverse effect of antifungal antibiotics, systemically used, initial encounter
  • T36.8X5AAdverse effect of other systemic antibiotics, initial encounter
  • T37.0X5AAdverse effect of sulfonamides, initial encounter
  • T37.1X5AAdverse effect of antimycobacterial drugs, initial encounter
  • T37.2X5AAdverse effect of antimalarials and drugs acting on other blood protozoa, initial encounter
  • T37.3X5AAdverse effect of other antiprotozoal drugs, initial encounter
  • T37.4X5AAdverse effect of anthelminthics, initial encounter
  • T37.5X5AAdverse effect of antiviral drugs, initial encounter
  • T37.8X5AAdverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter
  • T38.0X1APoisoning by glucocorticoids and synthetic analogues, accidental (unintentional), initial encounter
  • T38.0X2APoisoning by glucocorticoids and synthetic analogues, intentional self-harm, initial encounter
  • T38.0X3APoisoning by glucocorticoids and synthetic analogues, assault, initial encounter
  • T38.0X5AAdverse effect of glucocorticoids and synthetic analogues, initial encounter
  • T38.1X5AAdverse effect of thyroid hormones and substitutes, initial encounter
  • T38.2X5AAdverse effect of antithyroid drugs, initial encounter
  • T38.4X5AAdverse effect of oral contraceptives, initial encounter
  • T38.5X5AAdverse effect of other estrogens and progestogens, initial encounter
  • T38.6X5AAdverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter
  • T38.7X5AAdverse effect of androgens and anabolic congeners, initial encounter
  • T38.815AAdverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounter
  • T38.895AAdverse effect of other hormones and synthetic substitutes, initial encounter
  • T38.995AAdverse effect of other hormone antagonists, initial encounter
  • T39.015AAdverse effect of aspirin, initial encounter
  • T39.095AAdverse effect of salicylates, initial encounter
  • T39.1X5AAdverse effect of 4-Aminophenol derivatives, initial encounter
  • T39.2X5AAdverse effect of pyrazolone derivatives, initial encounter
  • T39.315AAdverse effect of propionic acid derivatives, initial encounter
  • T39.395AAdverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
  • T39.4X5AAdverse effect of antirheumatics, not elsewhere classified, initial encounter
  • T39.8X5AAdverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
  • T40.0X5AAdverse effect of opium, initial encounter
  • T40.2X1APoisoning by other opioids, accidental (unintentional), initial encounter
  • T40.2X3APoisoning by other opioids, assault, initial encounter
  • T40.2X4APoisoning by other opioids, undetermined, initial encounter
  • T40.2X5AAdverse effect of other opioids, initial encounter
  • T40.3X5AAdverse effect of methadone, initial encounter
  • T40.491APoisoning by other synthetic narcotics, accidental (unintentional), initial encounter
  • T40.492APoisoning by other synthetic narcotics, intentional self-harm, initial encounter
  • T40.493APoisoning by other synthetic narcotics, assault, initial encounter
  • T40.495AAdverse effect of other synthetic narcotics, initial encounter
  • T40.5X5AAdverse effect of cocaine, initial encounter
  • T40.691APoisoning by other narcotics, accidental (unintentional), initial encounter
  • T40.692APoisoning by other narcotics, intentional self-harm, initial encounter
  • T40.693APoisoning by other narcotics, assault, initial encounter
  • T40.695AAdverse effect of other narcotics, initial encounter
  • T40.715AAdverse effect of cannabis, initial encounter
  • T40.725AAdverse effect of synthetic cannabinoids, initial encounter
  • T40.995AAdverse effect of other psychodysleptics [hallucinogens], initial encounter
  • T41.0X5AAdverse effect of inhaled anesthetics, initial encounter
  • T41.1X5AAdverse effect of intravenous anesthetics, initial encounter
  • T41.295AAdverse effect of other general anesthetics, initial encounter
  • T41.3X5AAdverse effect of local anesthetics, initial encounter
  • T41.5X5AAdverse effect of therapeutic gases, initial encounter
  • T42.0X5AAdverse effect of hydantoin derivatives, initial encounter
  • T42.1X5AAdverse effect of iminostilbenes, initial encounter
  • T42.2X5AAdverse effect of succinimides and oxazolidinediones, initial encounter
  • T42.3X5AAdverse effect of barbiturates, initial encounter
  • T42.4X5AAdverse effect of benzodiazepines, initial encounter
  • T42.5X5AAdverse effect of mixed antiepileptics, initial encounter
  • T42.6X5AAdverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter
  • T42.8X5AAdverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
  • T43.015AAdverse effect of tricyclic antidepressants, initial encounter
  • T43.025AAdverse effect of tetracyclic antidepressants, initial encounter
  • T43.1X5AAdverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter
  • T43.215AAdverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
  • T43.225AAdverse effect of selective serotonin reuptake inhibitors, initial encounter
  • T43.295AAdverse effect of other antidepressants, initial encounter
  • T43.3X5AAdverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter
  • T43.4X5AAdverse effect of butyrophenone and thiothixene neuroleptics, initial encounter
  • T43.595AAdverse effect of other antipsychotics and neuroleptics, initial encounter
  • T43.615AAdverse effect of caffeine, initial encounter
  • T43.625AAdverse effect of amphetamines, initial encounter
  • T43.635AAdverse effect of methylphenidate, initial encounter
  • T43.641APoisoning by ecstasy, accidental (unintentional), initial encounter
  • T43.641DPoisoning by ecstasy, accidental (unintentional), subsequent encounter
  • T43.641SPoisoning by ecstasy, accidental (unintentional), sequela
  • T43.642APoisoning by ecstasy, intentional self-harm, initial encounter
  • T43.642DPoisoning by ecstasy, intentional self-harm, subsequent encounter
  • T43.642SPoisoning by ecstasy, intentional self-harm, sequela
  • T43.643APoisoning by ecstasy, assault, initial encounter
  • T43.643DPoisoning by ecstasy, assault, subsequent encounter
  • T43.643SPoisoning by ecstasy, assault, sequela
  • T43.644APoisoning by ecstasy, undetermined, initial encounter
  • T43.644DPoisoning by ecstasy, undetermined, subsequent encounter
  • T43.644SPoisoning by ecstasy, undetermined, sequela
  • T43.651APoisoning by methamphetamines accidental (unintentional), initial encounter
  • T43.651DPoisoning by methamphetamines accidental (unintentional), subsequent encounter
  • T43.651SPoisoning by methamphetamines accidental (unintentional), sequela
  • T43.652APoisoning by methamphetamines intentional self-harm, initial encounter
  • T43.652DPoisoning by methamphetamines intentional self-harm, subsequent encounter
  • T43.652SPoisoning by methamphetamines intentional self-harm, sequela
  • T43.653APoisoning by methamphetamines, assault, initial encounter
  • T43.653DPoisoning by methamphetamines, assault, subsequent encounter
  • T43.653SPoisoning by methamphetamines, assault, sequela
  • T43.654APoisoning by methamphetamines, undetermined, initial encounter
  • T43.654DPoisoning by methamphetamines, undetermined, subsequent encounter
  • T43.654SPoisoning by methamphetamines, undetermined, sequela
  • T43.655AAdverse effect of methamphetamines, initial encounter
  • T43.655DAdverse effect of methamphetamines, subsequent encounter
  • T43.655SAdverse effect of methamphetamines, sequela
  • T43.656AUnderdosing of methamphetamines, initial encounter
  • T43.656DUnderdosing of methamphetamines, subsequent encounter
  • T43.656SUnderdosing of methamphetamines, sequela
  • T43.695AAdverse effect of other psychostimulants, initial encounter
  • T43.8X5AAdverse effect of other psychotropic drugs, initial encounter
  • T44.0X5AAdverse effect of anticholinesterase agents, initial encounter
  • T44.1X5AAdverse effect of other parasympathomimetics [cholinergics], initial encounter
  • T44.2X1APoisoning by ganglionic blocking drugs, accidental (unintentional), initial encounter
  • T44.2X2APoisoning by ganglionic blocking drugs, intentional self-harm, initial encounter
  • T44.2X3APoisoning by ganglionic blocking drugs, assault, initial encounter
  • T44.2X5AAdverse effect of ganglionic blocking drugs, initial encounter
  • T44.3X5AAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
  • T44.4X5AAdverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter
  • T44.5X5AAdverse effect of predominantly beta-adrenoreceptor agonists, initial encounter
  • T44.6X5AAdverse effect of alpha-adrenoreceptor antagonists, initial encounter
  • T44.7X5AAdverse effect of beta-adrenoreceptor antagonists, initial encounter
  • T44.8X5AAdverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
  • T44.995AAdverse effect of other drug primarily affecting the autonomic nervous system, initial encounter
  • T45.0X1APoisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial encounter
  • T45.0X2APoisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter
  • T45.0X3APoisoning by antiallergic and antiemetic drugs, assault, initial encounter
  • T45.0X5AAdverse effect of antiallergic and antiemetic drugs, initial encounter
  • T45.1X1APoisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter
  • T45.1X2APoisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, initial encounter
  • T45.1X3APoisoning by antineoplastic and immunosuppressive drugs, assault, initial encounter
  • T45.1X5AAdverse effect of antineoplastic and immunosuppressive drugs, initial encounter
  • T45.1X5SAdverse effect of antineoplastic and immunosuppressive drugs, sequela
  • T45.2X5AAdverse effect of vitamins, initial encounter
  • T45.3X5AAdverse effect of enzymes, initial encounter
  • T45.4X5AAdverse effect of iron and its compounds, initial encounter
  • T45.515AAdverse effect of anticoagulants, initial encounter
  • T45.525AAdverse effect of antithrombotic drugs, initial encounter
  • T45.615AAdverse effect of thrombolytic drugs, initial encounter
  • T45.625AAdverse effect of hemostatic drug, initial encounter
  • T45.695AAdverse effect of other fibrinolysis-affecting drugs, initial encounter
  • T45.7X5AAdverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
  • T45.8X5AAdverse effect of other primarily systemic and hematological agents, initial encounter
  • T46.0X1APoisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
  • T46.0X2APoisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
  • T46.0X3APoisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
  • T46.0X5AAdverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
  • T46.1X1APoisoning by calcium-channel blockers, accidental (unintentional), initial encounter
  • T46.1X2APoisoning by calcium-channel blockers, intentional self-harm, initial encounter
  • T46.1X3APoisoning by calcium-channel blockers, assault, initial encounter
  • T46.1X5AAdverse effect of calcium-channel blockers, initial encounter
  • T46.2X1APoisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter
  • T46.2X2APoisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter
  • T46.2X3APoisoning by other antidysrhythmic drugs, assault, initial encounter
  • T46.2X5AAdverse effect of other antidysrhythmic drugs, initial encounter
  • T46.3X1APoisoning by coronary vasodilators, accidental (unintentional), initial encounter
  • T46.3X2APoisoning by coronary vasodilators, intentional self-harm, initial encounter
  • T46.3X3APoisoning by coronary vasodilators, assault, initial encounter
  • T46.3X5AAdverse effect of coronary vasodilators, initial encounter
  • T46.4X1APoisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter
  • T46.4X2APoisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter
  • T46.4X3APoisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter
  • T46.4X5AAdverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
  • T46.5X1APoisoning by other antihypertensive drugs, accidental (unintentional), initial encounter
  • T46.5X2APoisoning by other antihypertensive drugs, intentional self-harm, initial encounter
  • T46.5X3APoisoning by other antihypertensive drugs, assault, initial encounter
  • T46.5X5AAdverse effect of other antihypertensive drugs, initial encounter
  • T46.6X1APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounter
  • T46.6X2APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounter
  • T46.6X3APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, initial encounter
  • T46.6X5AAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
  • T46.7X1APoisoning by peripheral vasodilators, accidental (unintentional), initial encounter
  • T46.7X2APoisoning by peripheral vasodilators, intentional self-harm, initial encounter
  • T46.7X3APoisoning by peripheral vasodilators, assault, initial encounter
  • T46.7X5AAdverse effect of peripheral vasodilators, initial encounter
  • T46.8X1APoisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter
  • T46.8X2APoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter
  • T46.8X3APoisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter
  • T46.8X5AAdverse effect of antivaricose drugs, including sclerosing agents, initial encounter
  • T46.901APoisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
  • T46.902APoisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
  • T46.903APoisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter
  • T46.905AAdverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
  • T46.991APoisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
  • T46.992APoisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
  • T46.993APoisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter
  • T46.995AAdverse effect of other agents primarily affecting the cardiovascular system, initial encounter
  • T47.0X5AAdverse effect of histamine H2-receptor blockers, initial encounter
  • T47.1X5AAdverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
  • T47.2X5AAdverse effect of stimulant laxatives, initial encounter
  • T47.3X5AAdverse effect of saline and osmotic laxatives, initial encounter
  • T47.4X5AAdverse effect of other laxatives, initial encounter
  • T47.5X5AAdverse effect of digestants, initial encounter
  • T47.6X5AAdverse effect of antidiarrheal drugs, initial encounter
  • T47.7X5AAdverse effect of emetics, initial encounter
  • T47.8X5AAdverse effect of other agents primarily affecting gastrointestinal system, initial encounter
  • T48.0X5AAdverse effect of oxytocic drugs, initial encounter
  • T48.1X5AAdverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
  • T48.295AAdverse effect of other drugs acting on muscles, initial encounter
  • T48.3X5AAdverse effect of antitussives, initial encounter
  • T48.4X5AAdverse effect of expectorants, initial encounter
  • T48.5X5AAdverse effect of other anti-common-cold drugs, initial encounter
  • T48.6X5AAdverse effect of antiasthmatics, initial encounter
  • T48.995AAdverse effect of other agents primarily acting on the respiratory system, initial encounter
  • T49.0X5AAdverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
  • T49.1X5AAdverse effect of antipruritics, initial encounter
  • T49.2X5AAdverse effect of local astringents and local detergents, initial encounter
  • T49.3X5AAdverse effect of emollients, demulcents and protectants, initial encounter
  • T49.4X5AAdverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
  • T49.5X5AAdverse effect of ophthalmological drugs and preparations, initial encounter
  • T49.6X5AAdverse effect of otorhinolaryngological drugs and preparations, initial encounter
  • T49.7X5AAdverse effect of dental drugs, topically applied, initial encounter
  • T49.8X5AAdverse effect of other topical agents, initial encounter
  • T50.0X1APoisoning by mineralocorticoids and their antagonists, accidental (unintentional), initial encounter
  • T50.0X2APoisoning by mineralocorticoids and their antagonists, intentional self-harm, initial encounter
  • T50.0X3APoisoning by mineralocorticoids and their antagonists, assault, initial encounter
  • T50.0X5AAdverse effect of mineralocorticoids and their antagonists, initial encounter
  • T50.1X5AAdverse effect of loop [high-ceiling] diuretics, initial encounter
  • T50.2X5AAdverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
  • T50.3X5AAdverse effect of electrolytic, caloric and water-balance agents, initial encounter
  • T50.4X5AAdverse effect of drugs affecting uric acid metabolism, initial encounter
  • T50.5X5AAdverse effect of appetite depressants, initial encounter
  • T50.6X5AAdverse effect of antidotes and chelating agents, initial encounter
  • T50.7X5AAdverse effect of analeptics and opioid receptor antagonists, initial encounter
  • T50.8X5AAdverse effect of diagnostic agents, initial encounter
  • T50.A15AAdverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounter
  • T50.A25AAdverse effect of mixed bacterial vaccines without a pertussis component, initial encounter
  • T50.A95AAdverse effect of other bacterial vaccines, initial encounter
  • T50.B15AAdverse effect of smallpox vaccines, initial encounter
  • T50.B95AAdverse effect of other viral vaccines, initial encounter
  • T50.Z15AAdverse effect of immunoglobulin, initial encounter
  • T50.Z95AAdverse effect of other vaccines and biological substances, initial encounter
  • T50.905AAdverse effect of unspecified drugs, medicaments and biological substances, initial encounter
  • T50.995AAdverse effect of other drugs, medicaments and biological substances, initial encounter
  • T51.3X1AToxic effect of fusel oil, accidental (unintentional), initial encounter
  • T51.3X2AToxic effect of fusel oil, intentional self-harm, initial encounter
  • T51.3X3AToxic effect of fusel oil, assault, initial encounter
  • T58.01XAToxic effect of carbon monoxide from motor vehicle exhaust, accidental (unintentional), initial encounter
  • T58.02XAToxic effect of carbon monoxide from motor vehicle exhaust, intentional self-harm, initial encounter
  • T58.03XAToxic effect of carbon monoxide from motor vehicle exhaust, assault, initial encounter
  • T58.11XAToxic effect of carbon monoxide from utility gas, accidental (unintentional), initial encounter
  • T58.12XAToxic effect of carbon monoxide from utility gas, intentional self-harm, initial encounter
  • T58.13XAToxic effect of carbon monoxide from utility gas, assault, initial encounter
  • T58.2X1AToxic effect of carbon monoxide from incomplete combustion of other domestic fuels, accidental (unintentional), initial encounter
  • T58.2X2AToxic effect of carbon monoxide from incomplete combustion of other domestic fuels, intentional self-harm, initial encounter
  • T58.2X3AToxic effect of carbon monoxide from incomplete combustion of other domestic fuels, assault, initial encounter
  • T58.8X1AToxic effect of carbon monoxide from other source, accidental (unintentional), initial encounter
  • T58.8X2AToxic effect of carbon monoxide from other source, intentional self-harm, initial encounter
  • T58.8X3AToxic effect of carbon monoxide from other source, assault, initial encounter
  • T66.XXXARadiation sickness, unspecified, initial encounter
  • T75.01XAShock due to being struck by lightning, initial encounter
  • T75.09XAOther effects of lightning, initial encounter
  • T75.4XXAElectrocution, initial encounter
  • T79.0XXAAir embolism (traumatic), initial encounter
  • T79.1XXAFat embolism (traumatic), initial encounter
  • T79.4XXATraumatic shock, initial encounter
  • T80.0XXAAir embolism following infusion, transfusion and therapeutic injection, initial encounter
  • T80.211ABloodstream infection due to central venous catheter, initial encounter
  • T80.212ALocal infection due to central venous catheter, initial encounter
  • T80.218AOther infection due to central venous catheter, initial encounter
  • T80.22XAAcute infection following transfusion, infusion, or injection of blood and blood products, initial encounter
  • T80.29XAInfection following other infusion, transfusion and therapeutic injection, initial encounter
  • T80.51XAAnaphylactic reaction due to administration of blood and blood products, initial encounter
  • T80.52XAAnaphylactic reaction due to vaccination, initial encounter
  • T80.59XAAnaphylactic reaction due to other serum, initial encounter
  • T81.10XAPostprocedural shock unspecified, initial encounter
  • T81.11XAPostprocedural cardiogenic shock, initial encounter
  • T81.12XAPostprocedural septic shock, initial encounter
  • T81.19XAOther postprocedural shock, initial encounter
  • T81.40XAInfection following a procedure, unspecified, initial encounter
  • T81.40XDInfection following a procedure, unspecified, subsequent encounter
  • T81.40XSInfection following a procedure, unspecified, sequela
  • T81.41XAInfection following a procedure, superficial incisional surgical site, initial encounter
  • T81.41XDInfection following a procedure, superficial incisional surgical site, subsequent encounter
  • T81.41XSInfection following a procedure, superficial incisional surgical site, sequela
  • T81.42XAInfection following a procedure, deep incisional surgical site, initial encounter
  • T81.42XDInfection following a procedure, deep incisional surgical site, subsequent encounter
  • T81.42XSInfection following a procedure, deep incisional surgical site, sequela
  • T81.43XAInfection following a procedure, organ and space surgical site, initial encounter
  • T81.43XDInfection following a procedure, organ and space surgical site, subsequent encounter
  • T81.43XSInfection following a procedure, organ and space surgical site, sequela
  • T81.44XASepsis following a procedure, initial encounter
  • T81.44XDSepsis following a procedure, subsequent encounter
  • T81.44XSSepsis following a procedure, sequela
  • T81.49XAInfection following a procedure, other surgical site, initial encounter
  • T81.49XDInfection following a procedure, other surgical site, subsequent encounter
  • T81.49XSInfection following a procedure, other surgical site, sequela
  • T81.718AComplication of other artery following a procedure, not elsewhere classified, initial encounter
  • T81.72XAComplication of vein following a procedure, not elsewhere classified, initial encounter
  • T82.01XABreakdown (mechanical) of heart valve prosthesis, initial encounter
  • T82.02XADisplacement of heart valve prosthesis, initial encounter
  • T82.03XALeakage of heart valve prosthesis, initial encounter
  • T82.110ABreakdown (mechanical) of cardiac electrode, initial encounter
  • T82.111ABreakdown (mechanical) of cardiac pulse generator (battery), initial encounter
  • T82.118ABreakdown (mechanical) of other cardiac electronic device, initial encounter
  • T82.120ADisplacement of cardiac electrode, initial encounter
  • T82.121ADisplacement of cardiac pulse generator (battery), initial encounter
  • T82.128ADisplacement of other cardiac electronic device, initial encounter
  • T82.190AOther mechanical complication of cardiac electrode, initial encounter
  • T82.191AOther mechanical complication of cardiac pulse generator (battery), initial encounter
  • T82.198AOther mechanical complication of other cardiac electronic device, initial encounter
  • T82.211ABreakdown (mechanical) of coronary artery bypass graft, initial encounter
  • T82.212ADisplacement of coronary artery bypass graft, initial encounter
  • T82.213ALeakage of coronary artery bypass graft, initial encounter
  • T82.221ABreakdown (mechanical) of biological heart valve graft, initial encounter
  • T82.222ADisplacement of biological heart valve graft, initial encounter
  • T82.223ALeakage of biological heart valve graft, initial encounter
  • T82.228AOther mechanical complication of biological heart valve graft, initial encounter
  • T82.310ABreakdown (mechanical) of aortic (bifurcation) graft (replacement), initial encounter
  • T82.311ABreakdown (mechanical) of carotid arterial graft (bypass), initial encounter
  • T82.312ABreakdown (mechanical) of femoral arterial graft (bypass), initial encounter
  • T82.318ABreakdown (mechanical) of other vascular grafts, initial encounter
  • T82.320ADisplacement of aortic (bifurcation) graft (replacement), initial encounter
  • T82.321ADisplacement of carotid arterial graft (bypass), initial encounter
  • T82.322ADisplacement of femoral arterial graft (bypass), initial encounter
  • T82.328ADisplacement of other vascular grafts, initial encounter
  • T82.330ALeakage of aortic (bifurcation) graft (replacement), initial encounter
  • T82.331ALeakage of carotid arterial graft (bypass), initial encounter
  • T82.332ALeakage of femoral arterial graft (bypass), initial encounter
  • T82.338ALeakage of other vascular grafts, initial encounter
  • T82.390AOther mechanical complication of aortic (bifurcation) graft (replacement), initial encounter
  • T82.391AOther mechanical complication of carotid arterial graft (bypass), initial encounter
  • T82.392AOther mechanical complication of femoral arterial graft (bypass), initial encounter
  • T82.398AOther mechanical complication of other vascular grafts, initial encounter
  • T82.41XABreakdown (mechanical) of vascular dialysis catheter, initial encounter
  • T82.42XADisplacement of vascular dialysis catheter, initial encounter
  • T82.43XALeakage of vascular dialysis catheter, initial encounter
  • T82.510ABreakdown (mechanical) of surgically created arteriovenous fistula, initial encounter
  • T82.511ABreakdown (mechanical) of surgically created arteriovenous shunt, initial encounter
  • T82.512ABreakdown (mechanical) of artificial heart, initial encounter
  • T82.513ABreakdown (mechanical) of balloon (counterpulsation) device, initial encounter
  • T82.514ABreakdown (mechanical) of infusion catheter, initial encounter
  • T82.515ABreakdown (mechanical) of umbrella device, initial encounter
  • T82.518ABreakdown (mechanical) of other cardiac and vascular devices and implants, initial encounter
  • T82.520ADisplacement of surgically created arteriovenous fistula, initial encounter
  • T82.521ADisplacement of surgically created arteriovenous shunt, initial encounter
  • T82.522ADisplacement of artificial heart, initial encounter
  • T82.523ADisplacement of balloon (counterpulsation) device, initial encounter
  • T82.524ADisplacement of infusion catheter, initial encounter
  • T82.525ADisplacement of umbrella device, initial encounter
  • T82.528ADisplacement of other cardiac and vascular devices and implants, initial encounter
  • T82.530ALeakage of surgically created arteriovenous fistula, initial encounter
  • T82.531ALeakage of surgically created arteriovenous shunt, initial encounter
  • T82.532ALeakage of artificial heart, initial encounter
  • T82.533ALeakage of balloon (counterpulsation) device, initial encounter
  • T82.534ALeakage of infusion catheter, initial encounter
  • T82.535ALeakage of umbrella device, initial encounter
  • T82.538ALeakage of other cardiac and vascular devices and implants, initial encounter
  • T82.590AOther mechanical complication of surgically created arteriovenous fistula, initial encounter
  • T82.591AOther mechanical complication of surgically created arteriovenous shunt, initial encounter
  • T82.592AOther mechanical complication of artificial heart, initial encounter
  • T82.593AOther mechanical complication of balloon (counterpulsation) device, initial encounter
  • T82.594AOther mechanical complication of infusion catheter, initial encounter
  • T82.595AOther mechanical complication of umbrella device, initial encounter
  • T82.598AOther mechanical complication of other cardiac and vascular devices and implants, initial encounter
  • T82.6XXAInfection and inflammatory reaction due to cardiac valve prosthesis, initial encounter
  • T82.7XXAInfection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, initial encounter
  • T82.817AEmbolism due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.818AEmbolism due to vascular prosthetic devices, implants and grafts, initial encounter
  • T82.827AFibrosis due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.837AHemorrhage due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.847APain due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.857AStenosis of other cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.867AThrombosis due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.897AOther specified complication of cardiac prosthetic devices, implants and grafts, initial encounter
  • T84.51XAInfection and inflammatory reaction due to internal right hip prosthesis, initial encounter
  • T84.52XAInfection and inflammatory reaction due to internal left hip prosthesis, initial encounter
  • T84.53XAInfection and inflammatory reaction due to internal right knee prosthesis, initial encounter
  • T84.54XAInfection and inflammatory reaction due to internal left knee prosthesis, initial encounter
  • T84.59XAInfection and inflammatory reaction due to other internal joint prosthesis, initial encounter
  • T85.79XAInfection and inflammatory reaction due to other internal prosthetic devices, implants and grafts, initial encounter
  • T86.21Heart transplant rejection
  • T86.22Heart transplant failure
  • T86.23Heart transplant infection
  • T86.290Cardiac allograft vasculopathy
  • T86.298Other complications of heart transplant
  • T86.31Heart-lung transplant rejection
  • T86.32Heart-lung transplant failure
  • T86.33Heart-lung transplant infection
  • T86.39Other complications of heart-lung transplant
  • T88.0XXAInfection following immunization, initial encounter
  • T88.59XAOther complications of anesthesia, initial encounter
  • Z01.30Encounter for examination of blood pressure without abnormal findings
  • Z01.31Encounter for examination of blood pressure with abnormal findings
  • Z01.810Encounter for preprocedural cardiovascular examination
  • Z01.818Encounter for other preprocedural examination
  • Z01.82Encounter for allergy testing
  • Z01.89Encounter for other specified special examinations
  • Z09Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm
  • Z12.11Encounter for screening for malignant neoplasm of colon
  • Z13.6Encounter for screening for cardiovascular disorders
  • Z48.21Encounter for aftercare following heart transplant
  • Z48.22Encounter for aftercare following kidney transplant
  • Z48.23Encounter for aftercare following liver transplant
  • Z48.24Encounter for aftercare following lung transplant
  • Z48.280Encounter for aftercare following heart-lung transplant
  • Z48.288Encounter for aftercare following multiple organ transplant
  • Z48.290Encounter for aftercare following bone marrow transplant
  • Z48.298Encounter for aftercare following other organ transplant
  • Z51.11Encounter for antineoplastic chemotherapy
  • Z52.4Kidney donor
  • Z52.89Donor of other specified organs or tissues
  • Z79.3Long term (current) use of hormonal contraceptives
  • Z79.85Long-term (current) use of injectable non-insulin antidiabetic drugs
  • Z79.891Long term (current) use of opiate analgesic
  • Z79.899Other long term (current) drug therapy
  • Z86.711Personal history of pulmonary embolism
  • Z86.73Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits
  • Z86.74Personal history of sudden cardiac arrest
  • Z87.731Personal history of (corrected) tracheoesophageal fistula or atresia
  • Z87.760Personal history of (corrected) congenital diaphragmatic hernia or other congenital diaphragm malformations
  • Z94.1Heart transplant status
  • Z94.2Lung transplant status
  • Z94.3Heart and lungs transplant status
  • Z95.2Presence of prosthetic heart valve
  • Z95.3Presence of xenogenic heart valve
  • Z95.4Presence of other heart-valve replacement
  • Z95.811Presence of heart assist device
  • Z95.812Presence of fully implantable artificial heart
  • Z98.890Other specified postprocedural states
  • Z98.891History of uterine scar from previous surgery

Group 2 · 139 codes

  • D82.1Di George's syndrome
  • P22.8Other respiratory distress of newborn
  • P22.9Respiratory distress of newborn, unspecified
  • P28.31Primary central sleep apnea of newborn
  • P28.32Primary obstructive sleep apnea of newborn
  • P28.33Primary mixed sleep apnea of newborn
  • P28.39Other primary sleep apnea of newborn
  • P28.41Central neonatal apnea of newborn
  • P28.42Obstructive apnea of newborn
  • P28.43Mixed neonatal apnea of newborn
  • P28.49Other apnea of newborn
  • P28.89Other specified respiratory conditions of newborn
  • P29.0Neonatal cardiac failure
  • P29.11Neonatal tachycardia
  • P29.12Neonatal bradycardia
  • P29.2Neonatal hypertension
  • P29.30Pulmonary hypertension of newborn
  • P29.38Other persistent fetal circulation
  • P29.4Transient myocardial ischemia in newborn
  • P29.89Other cardiovascular disorders originating in the perinatal period
  • P94.1Congenital hypertonia
  • P94.2Congenital hypotonia
  • P94.8Other disorders of muscle tone of newborn
  • P96.0Congenital renal failure
  • P96.3Wide cranial sutures of newborn
  • P96.5Complication to newborn due to (fetal) intrauterine procedure
  • P96.89Other specified conditions originating in the perinatal period
  • Q20.0Common arterial trunk
  • Q20.1Double outlet right ventricle
  • Q20.2Double outlet left ventricle
  • Q20.3Discordant ventriculoarterial connection
  • Q20.4Double inlet ventricle
  • Q20.5Discordant atrioventricular connection
  • Q20.6Isomerism of atrial appendages
  • Q20.8Other congenital malformations of cardiac chambers and connections
  • Q21.0Ventricular septal defect
  • Q21.10Atrial septal defect, unspecified
  • Q21.11Secundum atrial septal defect
  • Q21.12Patent foramen ovale
  • Q21.13Coronary sinus atrial septal defect
  • Q21.14Superior sinus venosus atrial septal defect
  • Q21.15Inferior sinus venosus atrial septal defect
  • Q21.16Sinus venosus atrial septal defect, unspecified
  • Q21.19Other specified atrial septal defect
  • Q21.21Partial atrioventricular septal defect
  • Q21.22Transitional atrioventricular septal defect
  • Q21.23Complete atrioventricular septal defect
  • Q21.3Tetralogy of Fallot
  • Q21.4Aortopulmonary septal defect
  • Q21.8Other congenital malformations of cardiac septa
  • Q21.9Congenital malformation of cardiac septum, unspecified
  • Q22.0Pulmonary valve atresia
  • Q22.1Congenital pulmonary valve stenosis
  • Q22.2Congenital pulmonary valve insufficiency
  • Q22.3Other congenital malformations of pulmonary valve
  • Q22.4Congenital tricuspid stenosis
  • Q22.5Ebstein's anomaly
  • Q22.6Hypoplastic right heart syndrome
  • Q22.8Other congenital malformations of tricuspid valve
  • Q23.0Congenital stenosis of aortic valve
  • Q23.1Congenital insufficiency of aortic valve
  • Q23.2Congenital mitral stenosis
  • Q23.3Congenital mitral insufficiency
  • Q23.4Hypoplastic left heart syndrome
  • Q23.81Bicuspid aortic valve
  • Q24.0Dextrocardia
  • Q24.1Levocardia
  • Q24.2Cor triatriatum
  • Q24.3Pulmonary infundibular stenosis
  • Q24.4Congenital subaortic stenosis
  • Q24.5Malformation of coronary vessels
  • Q24.6Congenital heart block
  • Q24.8Other specified congenital malformations of heart
  • Q25.0Patent ductus arteriosus
  • Q25.1Coarctation of aorta
  • Q25.21Interruption of aortic arch
  • Q25.29Other atresia of aorta
  • Q25.3Supravalvular aortic stenosis
  • Q25.41Absence and aplasia of aorta
  • Q25.42Hypoplasia of aorta
  • Q25.43Congenital aneurysm of aorta
  • Q25.44Congenital dilation of aorta
  • Q25.45Double aortic arch
  • Q25.46Tortuous aortic arch
  • Q25.47Right aortic arch
  • Q25.48Anomalous origin of subclavian artery
  • Q25.49Other congenital malformations of aorta
  • Q25.5Atresia of pulmonary artery
  • Q25.6Stenosis of pulmonary artery
  • Q25.71Coarctation of pulmonary artery
  • Q25.72Congenital pulmonary arteriovenous malformation
  • Q25.79Other congenital malformations of pulmonary artery
  • Q25.8Other congenital malformations of other great arteries
  • Q26.0Congenital stenosis of vena cava
  • Q26.1Persistent left superior vena cava
  • Q26.2Total anomalous pulmonary venous connection
  • Q26.3Partial anomalous pulmonary venous connection
  • Q26.4Anomalous pulmonary venous connection, unspecified
  • Q26.8Other congenital malformations of great veins
  • Q26.9Congenital malformation of great vein, unspecified
  • Q27.0Congenital absence and hypoplasia of umbilical artery
  • Q27.9Congenital malformation of peripheral vascular system, unspecified
  • Q28.2Arteriovenous malformation of cerebral vessels
  • Q28.3Other malformations of cerebral vessels
  • Q28.9Congenital malformation of circulatory system, unspecified
  • Q30.0Choanal atresia
  • Q33.2Sequestration of lung
  • Q33.3Agenesis of lung
  • Q33.6Congenital hypoplasia and dysplasia of lung
  • Q40.1Congenital hiatus hernia
  • Q67.6Pectus excavatum
  • Q67.7Pectus carinatum
  • Q87.410Marfan syndrome with aortic dilation
  • Q87.418Marfan syndrome with other cardiovascular manifestations
  • Q87.42Marfan syndrome with ocular manifestations
  • Q87.43Marfan syndrome with skeletal manifestation
  • Q89.01Asplenia (congenital)
  • Q89.09Congenital malformations of spleen
  • Q89.3Situs inversus
  • Q89.7Multiple congenital malformations, not elsewhere classified
  • Q89.9Congenital malformation, unspecified
  • Q90.0Trisomy 21, nonmosaicism (meiotic nondisjunction)
  • Q90.1Trisomy 21, mosaicism (mitotic nondisjunction)
  • Q90.2Trisomy 21, translocation
  • Q91.0Trisomy 18, nonmosaicism (meiotic nondisjunction)
  • Q91.1Trisomy 18, mosaicism (mitotic nondisjunction)
  • Q91.2Trisomy 18, translocation
  • Q91.3Trisomy 18, unspecified
  • Q91.4Trisomy 13, nonmosaicism (meiotic nondisjunction)
  • Q91.5Trisomy 13, mosaicism (mitotic nondisjunction)
  • Q91.6Trisomy 13, translocation
  • Q96.0Karyotype 45, X
  • Q96.1Karyotype 46, X iso (Xq)
  • Q96.2Karyotype 46, X with abnormal sex chromosome, except iso (Xq)
  • Q96.3Mosaicism, 45, X/46, XX or XY
  • Q96.4Mosaicism, 45, X/other cell line(s) with abnormal sex chromosome
  • Q96.8Other variants of Turner's syndrome
  • R78.81Bacteremia
  • Z87.74Personal history of (corrected) congenital malformations of heart and circulatory system

Group 3 · 5 codes

  • I10Essential (primary) hypertension
  • I11.9Hypertensive heart disease without heart failure
  • I13.10Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
  • I13.11Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease
  • I15.0Renovascular hypertension

Group 4 · 203 codes

  • A18.84Tuberculosis of heart
  • I20.0Unstable angina
  • I20.1Angina pectoris with documented spasm
  • I20.81Angina pectoris with coronary microvascular dysfunction
  • I20.89Other forms of angina pectoris
  • I21.09ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall
  • I21.11ST elevation (STEMI) myocardial infarction involving right coronary artery
  • I21.19ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall
  • I21.29ST elevation (STEMI) myocardial infarction involving other sites
  • I21.4Non-ST elevation (NSTEMI) myocardial infarction
  • I24.0Acute coronary thrombosis not resulting in myocardial infarction
  • I24.1Dressler's syndrome
  • I24.81Acute coronary microvascular dysfunction
  • I24.89Other forms of acute ischemic heart disease
  • I25.10Atherosclerotic heart disease of native coronary artery without angina pectoris
  • I25.110Atherosclerotic heart disease of native coronary artery with unstable angina pectoris
  • I25.111Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm
  • I25.118Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris
  • I25.2Old myocardial infarction
  • I25.3Aneurysm of heart
  • I25.41Coronary artery aneurysm
  • I25.42Coronary artery dissection
  • I25.5Ischemic cardiomyopathy
  • I25.6Silent myocardial ischemia
  • I25.710Atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris
  • I25.711Atherosclerosis of autologous vein coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.718Atherosclerosis of autologous vein coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.720Atherosclerosis of autologous artery coronary artery bypass graft(s) with unstable angina pectoris
  • I25.721Atherosclerosis of autologous artery coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.728Atherosclerosis of autologous artery coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.730Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unstable angina pectoris
  • I25.731Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.738Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.750Atherosclerosis of native coronary artery of transplanted heart with unstable angina
  • I25.751Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm
  • I25.758Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris
  • I25.760Atherosclerosis of bypass graft of coronary artery of transplanted heart with unstable angina
  • I25.761Atherosclerosis of bypass graft of coronary artery of transplanted heart with angina pectoris with documented spasm
  • I25.768Atherosclerosis of bypass graft of coronary artery of transplanted heart with other forms of angina pectoris
  • I25.790Atherosclerosis of other coronary artery bypass graft(s) with unstable angina pectoris
  • I25.791Atherosclerosis of other coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.798Atherosclerosis of other coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.810Atherosclerosis of coronary artery bypass graft(s) without angina pectoris
  • I25.811Atherosclerosis of native coronary artery of transplanted heart without angina pectoris
  • I25.812Atherosclerosis of bypass graft of coronary artery of transplanted heart without angina pectoris
  • I25.82Chronic total occlusion of coronary artery
  • I25.84Coronary atherosclerosis due to calcified coronary lesion
  • I25.89Other forms of chronic ischemic heart disease
  • I27.0Primary pulmonary hypertension
  • I27.1Kyphoscoliotic heart disease
  • I27.20Pulmonary hypertension, unspecified
  • I27.21Secondary pulmonary arterial hypertension
  • I27.22Pulmonary hypertension due to left heart disease
  • I27.23Pulmonary hypertension due to lung diseases and hypoxia
  • I27.24Chronic thromboembolic pulmonary hypertension
  • I27.29Other secondary pulmonary hypertension
  • I27.82Chronic pulmonary embolism
  • I27.83Eisenmenger's syndrome
  • I27.840Fontan-associated liver disease [FALD]
  • I27.841Fontan-associated lymphatic dysfunction
  • I27.848Other Fontan-associated condition
  • I27.89Other specified pulmonary heart diseases
  • I34.0Nonrheumatic mitral (valve) insufficiency
  • I34.1Nonrheumatic mitral (valve) prolapse
  • I34.2Nonrheumatic mitral (valve) stenosis
  • I34.81Nonrheumatic mitral (valve) annulus calcification
  • I34.89Other nonrheumatic mitral valve disorders
  • I35.0Nonrheumatic aortic (valve) stenosis
  • I35.1Nonrheumatic aortic (valve) insufficiency
  • I35.2Nonrheumatic aortic (valve) stenosis with insufficiency
  • I35.8Other nonrheumatic aortic valve disorders
  • I42.00Dilated cardiomyopathy, unspecified
  • I42.01Familial-genetic dilated cardiomyopathy
  • I42.09Other dilated cardiomyopathy
  • I42.1Obstructive hypertrophic cardiomyopathy
  • I42.2Other hypertrophic cardiomyopathy
  • I42.4Endocardial fibroelastosis
  • I42.5Other restrictive cardiomyopathy
  • I42.6Alcoholic cardiomyopathy
  • I42.7Cardiomyopathy due to drug and external agent
  • I42.81Arrhythmogenic cardiomyopathy
  • I42.89Other cardiomyopathies not elsewhere classified
  • I43Cardiomyopathy in diseases classified elsewhere
  • I44.4Left anterior fascicular block
  • I44.5Left posterior fascicular block
  • I44.69Other fascicular block
  • I44.7Left bundle-branch block, unspecified
  • I45.0Right fascicular block
  • I45.19Other right bundle-branch block
  • I49.01Ventricular fibrillation
  • I49.02Ventricular flutter
  • I49.1Atrial premature depolarization
  • I49.2Junctional premature depolarization
  • I49.3Ventricular premature depolarization
  • I49.40Unspecified premature depolarization
  • I49.49Other premature depolarization
  • I50.1Left ventricular failure, unspecified
  • I50.20Unspecified systolic (congestive) heart failure
  • I50.21Acute systolic (congestive) heart failure
  • I50.22Chronic systolic (congestive) heart failure
  • I50.23Acute on chronic systolic (congestive) heart failure
  • I50.30Unspecified diastolic (congestive) heart failure
  • I50.31Acute diastolic (congestive) heart failure
  • I50.32Chronic diastolic (congestive) heart failure
  • I50.33Acute on chronic diastolic (congestive) heart failure
  • I50.40Unspecified combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.41Acute combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.42Chronic combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.43Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.9Heart failure, unspecified
  • I51.7Cardiomegaly
  • I97.0Postcardiotomy syndrome
  • I97.110Postprocedural cardiac insufficiency following cardiac surgery
  • I97.111Postprocedural cardiac insufficiency following other surgery
  • I97.120Postprocedural cardiac arrest following cardiac surgery
  • I97.121Postprocedural cardiac arrest following other surgery
  • I97.130Postprocedural heart failure following cardiac surgery
  • I97.131Postprocedural heart failure following other surgery
  • I97.190Other postprocedural cardiac functional disturbances following cardiac surgery
  • I97.191Other postprocedural cardiac functional disturbances following other surgery
  • Q24.0Dextrocardia
  • Q24.1Levocardia
  • Q24.2Cor triatriatum
  • Q24.3Pulmonary infundibular stenosis
  • Q24.4Congenital subaortic stenosis
  • R06.00Dyspnea, unspecified
  • R06.01Orthopnea
  • R06.02Shortness of breath
  • R06.09Other forms of dyspnea
  • R06.83Snoring
  • R06.89Other abnormalities of breathing
  • R07.2Precordial pain
  • R07.82Intercostal pain
  • R07.89Other chest pain
  • R07.9Chest pain, unspecified
  • R40.4Transient alteration of awareness
  • R55Syncope and collapse
  • R94.31Abnormal electrocardiogram [ECG] [EKG]
  • T82.310ABreakdown (mechanical) of aortic (bifurcation) graft (replacement), initial encounter
  • T82.311ABreakdown (mechanical) of carotid arterial graft (bypass), initial encounter
  • T82.312ABreakdown (mechanical) of femoral arterial graft (bypass), initial encounter
  • T82.318ABreakdown (mechanical) of other vascular grafts, initial encounter
  • T82.320ADisplacement of aortic (bifurcation) graft (replacement), initial encounter
  • T82.321ADisplacement of carotid arterial graft (bypass), initial encounter
  • T82.322ADisplacement of femoral arterial graft (bypass), initial encounter
  • T82.328ADisplacement of other vascular grafts, initial encounter
  • T82.330ALeakage of aortic (bifurcation) graft (replacement), initial encounter
  • T82.331ALeakage of carotid arterial graft (bypass), initial encounter
  • T82.332ALeakage of femoral arterial graft (bypass), initial encounter
  • T82.338ALeakage of other vascular grafts, initial encounter
  • T82.390AOther mechanical complication of aortic (bifurcation) graft (replacement), initial encounter
  • T82.391AOther mechanical complication of carotid arterial graft (bypass), initial encounter
  • T82.392AOther mechanical complication of femoral arterial graft (bypass), initial encounter
  • T82.398AOther mechanical complication of other vascular grafts, initial encounter
  • T82.41XABreakdown (mechanical) of vascular dialysis catheter, initial encounter
  • T82.42XADisplacement of vascular dialysis catheter, initial encounter
  • T82.43XALeakage of vascular dialysis catheter, initial encounter
  • T82.510ABreakdown (mechanical) of surgically created arteriovenous fistula, initial encounter
  • T82.511ABreakdown (mechanical) of surgically created arteriovenous shunt, initial encounter
  • T82.513ABreakdown (mechanical) of balloon (counterpulsation) device, initial encounter
  • T82.514ABreakdown (mechanical) of infusion catheter, initial encounter
  • T82.515ABreakdown (mechanical) of umbrella device, initial encounter
  • T82.518ABreakdown (mechanical) of other cardiac and vascular devices and implants, initial encounter
  • T82.520ADisplacement of surgically created arteriovenous fistula, initial encounter
  • T82.521ADisplacement of surgically created arteriovenous shunt, initial encounter
  • T82.523ADisplacement of balloon (counterpulsation) device, initial encounter
  • T82.524ADisplacement of infusion catheter, initial encounter
  • T82.525ADisplacement of umbrella device, initial encounter
  • T82.528ADisplacement of other cardiac and vascular devices and implants, initial encounter
  • T82.530ALeakage of surgically created arteriovenous fistula, initial encounter
  • T82.531ALeakage of surgically created arteriovenous shunt, initial encounter
  • T82.533ALeakage of balloon (counterpulsation) device, initial encounter
  • T82.534ALeakage of infusion catheter, initial encounter
  • T82.535ALeakage of umbrella device, initial encounter
  • T82.538ALeakage of other cardiac and vascular devices and implants, initial encounter
  • T82.590AOther mechanical complication of surgically created arteriovenous fistula, initial encounter
  • T82.591AOther mechanical complication of surgically created arteriovenous shunt, initial encounter
  • T82.593AOther mechanical complication of balloon (counterpulsation) device, initial encounter
  • T82.594AOther mechanical complication of infusion catheter, initial encounter
  • T82.595AOther mechanical complication of umbrella device, initial encounter
  • T82.598AOther mechanical complication of other cardiac and vascular devices and implants, initial encounter
  • T82.817AEmbolism due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.827AFibrosis due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.837AHemorrhage due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.847APain due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.857AStenosis of other cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.867AThrombosis due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.897AOther specified complication of cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.9XXAUnspecified complication of cardiac and vascular prosthetic device, implant and graft, initial encounter
  • T86.20Unspecified complication of heart transplant
  • T86.21Heart transplant rejection
  • T86.22Heart transplant failure
  • T86.23Heart transplant infection
  • T86.290Cardiac allograft vasculopathy
  • T86.298Other complications of heart transplant
  • T86.31Heart-lung transplant rejection
  • T86.32Heart-lung transplant failure
  • T86.33Heart-lung transplant infection
  • T86.39Other complications of heart-lung transplant
  • Z79.3Long term (current) use of hormonal contraceptives
  • Z79.83Long term (current) use of bisphosphonates
  • Z79.891Long term (current) use of opiate analgesic
  • Z79.899Other long term (current) drug therapy

Group 5 · 14 codes

  • I05.0Rheumatic mitral stenosis
  • I05.1Rheumatic mitral insufficiency
  • I05.2Rheumatic mitral stenosis with insufficiency
  • I05.8Other rheumatic mitral valve diseases
  • I08.0Rheumatic disorders of both mitral and aortic valves
  • I08.8Other rheumatic multiple valve diseases
  • I23.4Rupture of chordae tendineae as current complication following acute myocardial infarction
  • I23.5Rupture of papillary muscle as current complication following acute myocardial infarction
  • I33.0Acute and subacute infective endocarditis
  • I39Endocarditis and heart valve disorders in diseases classified elsewhere
  • I51.1Rupture of chordae tendineae, not elsewhere classified
  • I51.2Rupture of papillary muscle, not elsewhere classified
  • Q23.2Congenital mitral stenosis
  • Q23.3Congenital mitral insufficiency

* The article sets additional coding requirements for these codes (for example, a second diagnosis). Read them on the CMS article.

Disclaimer. This application provides informational coding and reimbursement reference data. It does not constitute legal, clinical, coding, or billing advice. Codes, payment amounts, payer rules, and coverage policies can change. Verify all information with current CMS publications, the applicable payer, and your organization’s compliance policies before submitting a claim. CodeRx is not affiliated with or endorsed by CMS, FDA, Medicare, or any payer.